To understand the clinical significance of BRPF1 alongside the members of MOZ–MORF and HBO1 complexes, we analyzed publicly available breast cancer patient data from The Cancer Genome Atlas (TCGA), which includes all breast cancer subtypes, such as luminal A, luminal B, Her2 and basal subtype. This evidence concerns the gene ERBB2 and breast carcinoma.